SEC Form 4 · accession 0001209191-15-063077
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
Jul 30, 2015
Accepted (ET)
Jul 31, 2015 · 1:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 30, 2015 | M | 860 | $83.36 | A | 19,235 | D | |
| Common Stock | Jul 30, 2015 | S | 100 | $123.17 | D | 19,135 | D | |
| Common Stock | Jul 30, 2015 | S | 100 | $125.54 | D | 19,035 | D | |
| Common StockF2,F3 | Jul 30, 2015 | S | 300 | $127.98 | D | 18,735 | D | |
| Common Stock | Jul 30, 2015 | S | 100 | $131.26 | D | 18,635 | D | |
| Common Stock | Jul 30, 2015 | S | 160 | $132.63 | D | 18,475 | D | |
| Common Stock | Jul 30, 2015 | S | 100 | $132.97 | D | 18,375 | D | |
| Common Stock | holding | — | — | — | 169 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $83.36 | Jul 30, 2015 | M | 860 | D | — | Jul 29, 2023 | Common Stock | 860 | 6,874 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $127.98 (range $127.60 to $128.51).
- F3Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4The option vests in 16 quarterly installments from 07/30/2013.